Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

Cited by (316)

Items 301–316 of 316

1. Purification protocol of hypertrophied hepatic stellate cells for their transcriptomic characterization from CDAHFD mice liver
   Marion Heckmann, Nour El Houda Djerir, Pierre‐Henri Commère, Julien Fernandes, Guillaume Sarrabayrouse, Pascal Bigey, Virginie Escriou, Céline Hoffmann · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
2. Low Hepatic CEACAM1 Tethers Metabolic Dysfunction Steatohepatitis to Atherosclerosis
   Sacha El Khoury, Sami N. Al Harake, Tya Youssef, Carl E. Risk, Naim G. Helou, Natalie M. Doumet, K. Aramouni, Sami Azar, Sonia M. Najjar, Hilda E. Ghadieh · 2025 · Livers
3. Liver immunology: Biological role and clinical significance
   Stanislav Nikolaevich Kotlyarov · 2025 · World Journal of Hepatology
4. Additional file 1 of Identification of functional genes in liver fibrosis based on bioinformatics analysis of a lncRNA-mediated ceRNA network
   Feng Zhang, Pei, Siya, Xiao, Meifang · 2024 · Figshare
5. The functional role of Claudin-1 as a mediator and therapeutic target in liver fibrogenesis and hepatocarcinogenesis
   Natascha Roehlen · 2021 · theses.fr (ABES)
6. Impact de la stéatohépatite non alcoolique sur le remodelage myocardique et sur les complications cardiovasculaires
   Raphaël Decoin · 2023
7. Purification and Transcriptomic Characterization of Hypertrophied Hepatic Stellate Cells From CDAHFD Mouse Liver
   Marion Heckmann, Nour El Houda Djerir, Keola Greliche, Pierre‐Henri Commère, Julien Fernandes, Guillaume Sarrabayrouse, Bernard Hainque, Pascal Bigey, Virginie Escriou, Céline Hoffmann · 2026 · The FASEB Journal
8. Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells
   Yeonseo Kim, Baknoon Ham, Yeojin Kim, Byung Hwa Jung, Jinyoung Park, Hyunbeom Lee · 2026 · Biochemical and Biophysical Research Communications
9. Annexin A2 Is Associated with Dietary Cholesterol-Induced Metabolic Dysregulation and the Progression of Hepatic Fibrosis
   Jiayang Liu, Ling Ou, Haiyan Tai, Yinghan Chai, Lirong Tan, Jie Lin, Bing Li, Ying Cao, Tingting Zhu · 2026 · Metabolites
10. Microbial Metabolomic Signatures Reveal Underlying Phenotypic Divergence in Lean and Obese Mice with MASH under Identical Dietary Stress
    Tanuja Mohanty, Anil Kumar Baidya, Palok Aich · 2026 · Journal of the American Society for Mass Spectrometry
11. Targeting hepatic cholesterol sensing to tackle metabolic dysfunction–associated steatohepatitis
    Mengwei Zang, Yu Li · 2026 · Journal of Clinical Investigation
12. Harnessing Natural Products as AMPK Activators: A Promising Therapeutic Avenue for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kun Wang, Hong Shen, Jing Shi, Jiajun Fu · 2026 · Revista Brasileira de Farmacognosia
13. Lutein mitigates high-fat-diet induced hepatic lipid accumulation and fibrosis by targeting Hmgcs1 in marine fish
    Yangguang Bao, Jiayun Zhu, Wenli Zhao, Xuran Liu, Tingting Zhu, Peng Sun, Qicun Zhou, Min Jin · 2026 · Marine Life Science & Technology
14. Lipotoxicity in MAFLD/MASH: cellular mechanisms and targetable nodes
    Joseph Tawai, Kairan Zhou, Jing Xiong · 2026 · Targetome
15. Hepatic Stellate Cell Heterogeneity in Chronic Liver Fibrosis: Functional States and Translational Opportunities
    Rui Chen, Yufei Yang, Guangwen Chen, Xiaobo Cai, Lungen Lu, Qichao Ge · 2026 · Journal of Translational Gastroenterology
16. BindingDB Entry 50017780: Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol.
    BindingDB · 2023 · UC San Diego